Delivery Order SPE2DB24D2101-SPE2DB25FKNXT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,707.48 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 14, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (quantity 60) under a firm fixed-price contract valued at $4,135.61, with an ultimate completion date of August 4, 2025. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100-count), with a contract ceiling value of $28,600.52. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside procurement supporting federal pharmaceutical supply needs. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rifampin 300 mg capsules in unit dose packages of 100 units. This competitively awarded contract, valued at $2,276.64 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The order is scheduled for completion by August 18, 2025, with fulfillment performed at the contractor's facility in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,089.08. The contract is firm fixed price with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025, with no set-aside designation. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.74 to AmerisourceBergen Drug Corp for 60-count bottles of Rifampin 300 mg capsules, with delivery to the company's headquarters in Conshohocken, Pennsylvania. The contract was awarded on August 6, 2025, under firm fixed price terms with an ultimate completion date of August 7, 2025, and utilized no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Rifampin 300 mg capsules (30-count units) with a ceiling value of $1,789.57. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,570.68 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Rifampin 300 mg capsules (60 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,200.66 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNXTDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) valued at $2,401.32, with an ultimate completion date of August 27, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order fulfills federal pharmaceutical procurement needs for military and veteran healthcare systems. Rifampin is an antibiotic commonly used to treat tuberculosis and other mycobacterial infections, making it a critical pharmaceutical commodity for the Defense Health Agency and related military healthcare programs. As a major pharmaceutical distributor serving federal medical supply chains, AmerisourceBergen has demonstrated substantial capacity to meet competitive federal procurement requirements across a comprehensive portfolio of therapeutic domains, from specialty medications to vaccines and medical supplies, consistently delivering through firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/26/25 |